Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999

European Journal of Surgical Oncology

Volumn 32, Issue 9, 2006, Pages 974-979

  Bacci, G ^a   Longhi, A ^a   Ferrari, S ^a   Mercuri, M ^a   Barbieri, E ^b   Bertoni, F ^a   Bacchini, P ^a   Picci, P ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Ewing's sarcoma; Extremity; Neoadjuvant chemotherapy; Radiotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BONE METASTASIS; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; EWING SARCOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LUNG LOBECTOMY; LUNG METASTASIS; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; ORTHOPEDIC SURGERY; OVERALL SURVIVAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TIME; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT; MALE; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA, EWING'S; TREATMENT OUTCOME;

EID: 33750357599     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.01.023     Document Type: Article

References (25)

1. Phillips R.F., and Higinbotham N.L. The curability of Ewing's endothelioma of bone in children. J Pediatr 70 (1967) 391-397
2. Burgert E.O., Nesbit M.E., Garnsey L.A., et al. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone, intergroup study IESS-II. J Clin Oncol 8 (1990) 1514-1525
3. Nilbert M., Saeter G., Elomaa I., Monge O.R., Wiebe T., and Avegard T.A. Ewing's sarcoma treatment in Scandinavia 1984-1990: ten-year results of the Scandinavian Sarcoma Group Protocol SSG-IV. Acta Oncol 37 (1998) 375-378
4. Oberlin O., Deley M.C., Bui B.N., et al. Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Pediatric Oncology (EW88 study). Br J Cancer 30 (2001) 1646-1654
5. Craft A.W., Cotterill S.J., Bullimore J.A., and Pearson D. Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party. Eur J Cancer 33 (1997) 1061-1069
6. Paulussen M., Ahrens S., Dunst J., et al. Localized Ewing tumor of bone: final results of the Cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 19 (2001) 1818-1829
7. Grier H.E., Krailo M.D., Tarbell N.J., et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348 (2003) 694-701
8. Bacci G., Mercuri M., Longhi A., et al. Neoadjuvant chemotherapy for Ewing's tumor of bone; recent experience at the Rizzoli Orthopaedic Institute. Eur J Cancer 38 (2002) 2243-2251
9. Bacci G., Ferrari S., Longhi A., et al. Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy. Eur J cancer 37 (2001) 32-38
10. Goorin A.M., Shuster J.J., Baker A., Horowitz M.E., Meyer W.H., and Link M.P. Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study. J Clin Oncol 9 (1991) 600-605
11. Bacci G., Toni A., Avella M., et al. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy. Cancer 63 (1989) 1477-1486
12. Bacci G., Picci P., Ferrari S., et al. Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase: results of two sequential studies. Cancer 82 (1998) 1174-1183
13. Picci P., Bohling T., Bacci G., et al. Chemotherapy induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol 15 (1997) 1553-1559
14. Rodriguez-Galindo C., Billups C.A., Kun L.E., et al. Survival after recurrence of Ewing tumors: the ST Jude Children's Research Hospital experience, 1979-1999. Cancer 94 (2002) 561-569
15. Sauer R., Jurgens H., Burgers J.M., Dunst J., Hawlicek R., and Michaelis J. Prognostic factors in the treatment of Ewing's sarcoma. The Ewing's Sarcoma Study Group of the German Society of Pediatric Oncology CESS 81. Radither Oncol 10 (1987) 101-110
16. Oberlin O., Habrand J.L., Zucker J.M., et al. No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Paediatric Oncology. J Clin Oncol 10 (1992) 1407-1412
17. Vietti T.J., Gehan E.A., Nesbit M.E., et al. J Natl Cancer Inst Monogr 56 (1981) 279-284
18. Cangir A., Vietti T.J., Gehan E.A., et al. Ewing's sarcoma metastatic at diagnosis. Results and comparisons of two intergroup Ewing's sarcoma studies. Cancer 66 (1990) 887-893
19. Hayes F.A., Thompson E.I., Parvey L., et al. Metastatic Ewing's sarcoma: remission induction and survival. J Clin Oncol 5 (1987) 1199-1204
20. Paulussen M., Arhens S., Craft A.W., et al. Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients. J Clin Oncol 16 (1998) 3044-3052
21. Miser J.S., Krailo M.D., Tarbell N.J., et al. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination of ifosfamide and etoposide: a Children's Cancer Group and Pediatric Oncology Group study. J Clin Oncol 22 (2004) 2873-2876
22. Burdach S., Meyer-Bahlburg A., Laws H.J., et al. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation. J Clin Oncol 21 (2003) 3072-3078
23. Horowitz M.E., Kinsella T.J., Wexler L.H., et al. Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 11 (1993) 1911-1918
24. Ladenstein R., Lasset C., Pinkerton R., et al. Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumor Registry. Bone Marrow Transplant 15 (1995) 697-705
25. Meyers P.A., Krailo M.D., Ladanyi M., et al. High-dose melphalan etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol 19 (2001) 2812-2820